Lead Engineering Technician - Global GMARS Maintenance & Reliability at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Healthcare, ManufacturingIndustries

Requirements

High School Diploma/GED
10 years work experience in maintenance or engineering (plant and/or reliability)

Responsibilities

Provide technical and discipline support focused on Planning/Scheduling/Performing Maintenance, Materials Management, Equipment Reliability, Calibration, and Metrology
Offer global assistance to sites in Maintenance and Laboratory Asset Management, including troubleshooting, root cause analysis and resolution, future planning, site assessments, and consultations
Provide ongoing technical support and mentoring to site plant engineering and maintenance groups, domestic and global, at new and existing Manufacturing and Laboratory sites
Assist in the development and delivery of Maximo user training and associated training materials
Assist in the development and delivery of GMARS user training and associated training materials
Partner with technical staff and external partners to ensure proper execution of maintenance and reliability practices
Support continuous improvements and efficient use of Maximo, including aiding in the development, testing, and deployment of new software releases alongside the Lilly IT team
Manage Maximo Change Control, including drafting and revising changes, and participating in and leading meetings for the Maximo Change Control Board
Monitor the effectiveness of Maximo, gather user feedback, and recommend improvements
Facilitate standardized implementation and operational support of IBM Maximo – Enterprise Asset Management System, including technical consulting, end user training, managing training and resource documents, compliance assistance, and support for daily operations
Oversee the Global Maximo Community of Practice SharePoint and Viva Engage pages
Facilitate Global Maximo Community of Practice meetings on topics such as condition-based maintenance, reliability, system security, and system roles and responsibilities (e.g., Data Administration, Planning/Scheduling, Maintenance Supervision, Craftsperson, Materials Management, and Calibration) for Lilly manufacturing and laboratory sites

Skills

IBM Maximo

Enterprise Asset Management

SharePoint

Viva Engage

Maintenance Planning

Scheduling

Materials Management

Equipment Reliability

Calibration

Metrology

Condition-based Maintenance

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free